Promedior appoints Elizabeth Trehu CMO
This article was originally published in Scrip
Executive Summary
Promedior, a clinical stage biotech company developing novel biologic therapeutics for the treatment of fibrosis, has appointed Dr Elizabeth Trehu chief medical officer. Dr Trehu was most recently vice-president of product development and medical affairs at Infinity Pharmaceuticals, and previously spent four years at Genzyme.